Muscle Sympathetic Nerve Activity is Related to a Surrogate Marker of Endothelial Function in Healthy Individuals

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Feb 23

PMID 20174639

Citations 19

Authors

Yrsa Bergmann Sverrisdottir

Linda Marie Jansson

Ulrika Hagg

Li-Ming Gan

Affiliations

Soon will be listed here.

Abstract

Background: Evidence from animal studies indicates the importance of an interaction between the sympathetic nervous system and the endothelium for cardiovascular regulation. However the interaction between these two systems remains largely unexplored in humans. The aim of this study was to investigate whether directly recorded sympathetic vasoconstrictor outflow is related to a surrogate marker of endothelial function in healthy individuals.

Methods And Results: In 10 healthy normotensive subjects (3 f/7 m), (age 37+/-11 yrs), (BMI 24+/-3 kg/m(2)) direct recordings of sympathetic action potentials to the muscle vascular bed (MSNA) were performed and endothelial function estimated with the Reactive Hyperaemia- Peripheral Arterial Tonometry (RH-PAT) technique. Blood samples were taken and time spent on leisure-time physical activities was estimated. In all subjects the rate between resting flow and the maximum flow, the Reactive Hyperemic index (RH-PAT index), was within the normal range (1.9-3.3) and MSNA was as expected for age and gender (13-44 burst/minute). RH-PAT index was inversely related to MSNA (r = -0.8, p = 0.005). RH-PAT index and MSNA were reciprocally related to time (h/week) spent on physical activity (p = 0.005 and p = 0.006 respectively) and platelet concentration (PLT) (p = 0.02 and p = 0.004 respectively).

Conclusions: Our results show that sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy normotensive individuals, indicating that sympathetic outflow may be modulated by changes in endothelial function. In this study time spent on physical activity is identified as a predictor of sympathetic nerve activity and endothelial function in a group of healthy individuals. The results are of importance in understanding mechanisms underlying sympathetic activation in conditions associated with endothelial dysfunction and emphasise the importance of a daily exercise routine for maintenance of cardiovascular health.

Citing Articles

Does endothelial ischemic reperfusion injury augment sympathetic neurovascular transduction?.

Nardone M, Sayegh A, Fan J, Fisher J Clin Auton Res. 2024; 34(3):375-378.

PMID: 38767808 DOI: 10.1007/s10286-024-01037-0.

High-glycemic index meal acutely potentiates blood pressure response to static handgrip exercise in healthy humans.

Kashima H, Yamaoka Endo M, Kanda M, Miura A, Fukuba Y, Mizuno M J Appl Physiol (1985). 2023; 135(3):609-620.

PMID: 37471212 PMC: 10538994. DOI: 10.1152/japplphysiol.00703.2022.

Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae.

Faria D, Moll-Bernardes R, Testa L, Moniz C, Rodrigues E, Rodrigues A Hypertension. 2022; 80(2):470-481.

PMID: 36416143 PMC: 9847692. DOI: 10.1161/HYPERTENSIONAHA.122.19958.

Self-reported total sitting time on a non-working day is associated with blunted flow-mediated vasodilation and blunted nitroglycerine-induced vasodilation.

Yamaji T, Harada T, Hashimoto Y, Nakano Y, Kajikawa M, Yoshimura K Sci Rep. 2022; 12(1):6366.

PMID: 35430619 PMC: 9012897. DOI: 10.1038/s41598-022-10242-8.

Clinical Relevance of the Sympathetic-Vascular Interactions in Health and Disease.

Quarti-Trevano F, Seravalle G, Grassi G Biomedicines. 2021; 9(8).

PMID: 34440211 PMC: 8394495. DOI: 10.3390/biomedicines9081007.

References

Ng A, Callister R, Johnson D, Seals D . Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension. 1993; 21(4):498-503. DOI: 10.1161/01.hyp.21.4.498. View

Boger R . Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans. J Endocrinol Invest. 1999; 22(5 Suppl):75-81. View

Fukai T, Siegfried M, Ushio-Fukai M, Cheng Y, Kojda G, Harrison D . Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000; 105(11):1631-9. PMC: 300857. DOI: 10.1172/JCI9551. View

Somers V, Dyken M, Mark A, Abboud F . Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993; 328(5):303-7. DOI: 10.1056/NEJM199302043280502. View

Kingwell B . Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J. 2000; 14(12):1685-96. DOI: 10.1096/fj.99-0896rev. View

Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G . Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation. 2001; 103(13):1721-6. DOI: 10.1161/01.cir.103.13.1721. View

Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S . Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000; 342(7):454-60. DOI: 10.1056/NEJM200002173420702. View

Gao L, Wang W, Liu D, Zucker I . Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation. 2007; 115(24):3095-102. DOI: 10.1161/CIRCULATIONAHA.106.677989. View

Sartori C, Lepori M, Scherrer U . Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharmacol Ther. 2005; 106(2):209-20. DOI: 10.1016/j.pharmthera.2004.11.009. View

10.

Ray C, HUME K . Sympathetic neural adaptations to exercise training in humans: insights from microneurography. Med Sci Sports Exerc. 1998; 30(3):387-91. DOI: 10.1097/00005768-199803000-00008. View

11.

Cai H, Harrison D . Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000; 87(10):840-4. DOI: 10.1161/01.res.87.10.840. View

12.

Esler M, Kaye D . Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2001; 35(7 Suppl 4):S1-7. DOI: 10.1097/00005344-200000004-00001. View

13.

Owlya R, VOLLENWEIDER L, Trueb L, Sartori C, Lepori M, NICOD P . Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation. 1997; 96(11):3897-903. DOI: 10.1161/01.cir.96.11.3897. View

14.

Sverrisdottir Y, Elam M, Herlitz H, Bengtsson B, Johannsson G . Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab. 1998; 83(6):1881-5. DOI: 10.1210/jcem.83.6.4895. View

15.

Kojda G, Harrison D . Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 2000; 43(3):562-71. DOI: 10.1016/s0008-6363(99)00169-8. View

16.

Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G . Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989; 13(6 Pt 1):647-55. DOI: 10.1161/01.hyp.13.6.647. View

17.

Orshal J, Khalil R . Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004; 286(2):R233-49. DOI: 10.1152/ajpregu.00338.2003. View

18.

Bonetti P, Barsness G, Keelan P, Schnell T, Pumper G, Kuvin J . Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003; 41(10):1761-8. DOI: 10.1016/s0735-1097(03)00329-2. View

19.

Sverrisdottir Y, Mogren T, Kataoka J, Janson P, Stener-Victorin E . Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?. Am J Physiol Endocrinol Metab. 2008; 294(3):E576-81. DOI: 10.1152/ajpendo.00725.2007. View

20.

Panza J . Endothelial dysfunction in essential hypertension. Clin Cardiol. 1998; 20(11 Suppl 2):II-26-33. View